Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(42 sites)

France

Centre Hospitalier Universitaire (CHU) Amiens-Picardie - Hopital Sud, Amiens

CHU Jean Minjoz, Besançon

Hopital Michallon, Grenoble

CHRU Lille- Hopital Claude Huriez, Lille

CHU de Nantes - Hotel Dieu, Nantes